NO20081676L - Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika - Google Patents
Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytikaInfo
- Publication number
- NO20081676L NO20081676L NO20081676A NO20081676A NO20081676L NO 20081676 L NO20081676 L NO 20081676L NO 20081676 A NO20081676 A NO 20081676A NO 20081676 A NO20081676 A NO 20081676A NO 20081676 L NO20081676 L NO 20081676L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- amides
- bicyclic aryl
- thiadlazol
- pharmaceuticals
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 102000023984 PPAR alpha Human genes 0.000 abstract 1
- 229940080774 Peroxisome proliferator-activated receptor gamma agonist Drugs 0.000 abstract 1
- -1 bicyclic aryl sulfonic acid [1,3,4] thiadiazol-2-yl amides Chemical class 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003210 demyelinating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004129 fatty acid metabolism Effects 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05021785 | 2005-10-06 | ||
| PCT/EP2006/009300 WO2007039174A2 (fr) | 2005-10-06 | 2006-09-26 | [1,3,4]-thiadiazol-2-yl-amides bicycliques de l'acide aryl-sulfonique, leurs procedes de preparation, et leur utilisation en tant que substances pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081676L true NO20081676L (no) | 2008-04-29 |
Family
ID=45219048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081676A NO20081676L (no) | 2005-10-06 | 2008-04-04 | Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7612104B2 (fr) |
| EP (1) | EP1937675B1 (fr) |
| JP (1) | JP2009510146A (fr) |
| KR (1) | KR20080050607A (fr) |
| CN (1) | CN101282969A (fr) |
| AR (1) | AR056563A1 (fr) |
| AT (1) | ATE513829T1 (fr) |
| AU (1) | AU2006299088A1 (fr) |
| BR (1) | BRPI0616872A2 (fr) |
| CA (1) | CA2624329A1 (fr) |
| IL (1) | IL190459A0 (fr) |
| MA (1) | MA29811B1 (fr) |
| NO (1) | NO20081676L (fr) |
| NZ (1) | NZ567204A (fr) |
| RU (1) | RU2008113209A (fr) |
| TW (1) | TW200811120A (fr) |
| UY (1) | UY29848A1 (fr) |
| WO (1) | WO2007039174A2 (fr) |
| ZA (1) | ZA200801989B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY32442A (es) | 2009-02-13 | 2010-09-30 | Sanofi Aventis | Nuevos indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
| AR075402A1 (es) | 2009-02-13 | 2011-03-30 | Sanofi Aventis | Derivados heterociclicos oxigenados y/o nitrogenados de tetrahidronaftaleno, medicamentos que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad,entre otros. |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| GB201810581D0 (en) | 2018-06-28 | 2018-08-15 | Ctxt Pty Ltd | Compounds |
| HUE064683T2 (hu) | 2019-06-18 | 2024-04-28 | Pfizer | Benzoxazol-szulfonamid származékok |
| CN116041230B (zh) * | 2023-01-08 | 2024-03-19 | 中国海洋大学 | 一种nlrp3炎症小体抑制剂及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670282B2 (de) * | 1967-10-24 | 1977-02-24 | Antidiabetisch wirksame hydrindensulfonylamino-pyrimidine sowie verfahren zu deren herstellung | |
| DE2533605A1 (de) * | 1975-07-26 | 1977-02-03 | Bayer Ag | Antiparasitenmittel |
| US5097669A (en) * | 1991-02-11 | 1992-03-24 | Westinghouse Electric Corp. | Control of hydrogen cooler employed in power generators |
| HK1049325A1 (en) * | 2000-04-28 | 2003-05-09 | Sankyo Company, Limited | Ppar (gamma) modulators |
| CN100447139C (zh) * | 2003-07-08 | 2008-12-31 | 诺瓦提斯公司 | 苯磺酰氨基化合物和含有这些化合物的药物组合物 |
| MX2007015726A (es) | 2005-06-09 | 2008-03-04 | Vertex Pharma | Derivados de indano como moduladores de canales ionicos. |
-
2006
- 2006-09-26 WO PCT/EP2006/009300 patent/WO2007039174A2/fr not_active Ceased
- 2006-09-26 KR KR1020087008253A patent/KR20080050607A/ko not_active Withdrawn
- 2006-09-26 AU AU2006299088A patent/AU2006299088A1/en not_active Abandoned
- 2006-09-26 BR BRPI0616872-8A patent/BRPI0616872A2/pt not_active IP Right Cessation
- 2006-09-26 NZ NZ567204A patent/NZ567204A/en not_active IP Right Cessation
- 2006-09-26 RU RU2008113209/04A patent/RU2008113209A/ru not_active Application Discontinuation
- 2006-09-26 JP JP2008533906A patent/JP2009510146A/ja not_active Abandoned
- 2006-09-26 EP EP06792248A patent/EP1937675B1/fr active Active
- 2006-09-26 AT AT06792248T patent/ATE513829T1/de not_active IP Right Cessation
- 2006-09-26 CA CA002624329A patent/CA2624329A1/fr not_active Abandoned
- 2006-09-26 CN CNA2006800370553A patent/CN101282969A/zh active Pending
- 2006-09-27 TW TW095135655A patent/TW200811120A/zh unknown
- 2006-10-04 AR ARP060104362A patent/AR056563A1/es not_active Application Discontinuation
- 2006-10-06 UY UY29848A patent/UY29848A1/es not_active Application Discontinuation
-
2008
- 2008-03-03 ZA ZA200801989A patent/ZA200801989B/xx unknown
- 2008-03-26 IL IL190459A patent/IL190459A0/en unknown
- 2008-03-31 MA MA30789A patent/MA29811B1/fr unknown
- 2008-04-04 NO NO20081676A patent/NO20081676L/no not_active Application Discontinuation
- 2008-04-04 US US12/062,759 patent/US7612104B2/en not_active Expired - Fee Related
-
2009
- 2009-09-24 US US12/566,179 patent/US7772257B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7772257B2 (en) | 2010-08-10 |
| CA2624329A1 (fr) | 2007-04-12 |
| ATE513829T1 (de) | 2011-07-15 |
| CN101282969A (zh) | 2008-10-08 |
| RU2008113209A (ru) | 2009-10-10 |
| MA29811B1 (fr) | 2008-09-01 |
| US7612104B2 (en) | 2009-11-03 |
| EP1937675B1 (fr) | 2011-06-22 |
| IL190459A0 (en) | 2008-11-03 |
| US20080293780A1 (en) | 2008-11-27 |
| KR20080050607A (ko) | 2008-06-09 |
| BRPI0616872A2 (pt) | 2011-07-05 |
| NZ567204A (en) | 2010-06-25 |
| JP2009510146A (ja) | 2009-03-12 |
| ZA200801989B (en) | 2009-08-26 |
| WO2007039174A3 (fr) | 2007-08-09 |
| US20100022603A1 (en) | 2010-01-28 |
| WO2007039174A2 (fr) | 2007-04-12 |
| TW200811120A (en) | 2008-03-01 |
| AR056563A1 (es) | 2007-10-10 |
| AU2006299088A1 (en) | 2007-04-12 |
| UY29848A1 (es) | 2007-05-31 |
| EP1937675A2 (fr) | 2008-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092293L (no) | Sulfonyl-fenyl-2H-[1,2,4]oksodiazol-5-onderivater, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytiske midler | |
| NO20081367L (no) | Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika | |
| NO20081682L (no) | 4-oksy-N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika | |
| NO20081369L (no) | Fenyl- og pyridinyl-1,2,4-oksadiazolonderivater, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika | |
| NO20081681L (no) | N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| MX2010006647A (es) | Piridil-n-[1,3,4]-tiadiazol-2-il-bencenosulfonamidas ciclicas, procedimientos para su preparacion y su uso como productos farmaceuticos. | |
| NO20081676L (no) | Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| MX2007002689A (es) | 7-azaindoles y su uso como agonistas de ppar. | |
| TW200505880A (en) | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| TW200510352A (en) | Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals | |
| UA84203C2 (en) | Oxadiazolone derivatives as ppar delta agonists | |
| NO20064951L (no) | 1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse | |
| NO20081675L (no) | Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| TW200621732A (en) | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
| NO20064982L (no) | 1,3,4-oksadiazol-2-oner som PPAR delta modulatorer og anvendelse derav | |
| NO20081368L (no) | Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika | |
| TW200510399A (en) | 1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals | |
| TW200505830A (en) | Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
| NO20063860L (no) | 7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler | |
| TW200508229A (en) | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals | |
| TW200730516A (en) | Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals | |
| NO20055889L (no) | 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser | |
| TW200738654A (en) | Alkoxymethyl-substituted benzoic acid derivatives, process for their preparation and their use as medicaments | |
| TH88744B (th) | ไบไซคลิคแอริล-ซัลโฟนิคแอซิด[1,3,4]-ไธอะไดแอโซล-2-อิล-แอมีด, กรรมวิธีสำหรับการเตรียมสารเหล่านั้นและการใช้สารเหล่านั้นเป็นสารเภสัชกรรม |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |